The risk of developing Alzheimer's disease and dementia-related symptoms is higher in those with TBI and PTSD who carry the APOE E4 gene.
Exercise helped to reduce cognitive decline two years later in Parkinson's patients with the APOE e4 gene variant.
People with the Alzheimer's associated ApoE e4e4 gene have increased vulnerability to developing severe symptoms of COVID-19 if they become infected with the virus. Findings suggest those with the dementia-related gene have double the risk of developing severe coronavirus symptoms compared to those who those with the common e3e3 form of the APOE gene.
Carriers of one copy of the longevity associated klotho gene reduces Alzheimer's risks by 30% for those with genetic risk factors for the neurodegenerative disease.
Findings support the hypothesis that higher levels of amyloid in the brain is an indicator of the early stages of Alzheimer's disease.
While genetics may increase your risk of developing dementia, other factors such as lifestyle and environment may play a key role in the development and progression of Alzheimer's disease.
Sharp-wave ripple activity in the brain may be an early biomarker for Alzheimer's disease before cognitive impairment begins.
Study reveals there is no link between memory decline and statin use in older adults. Additionally, no association was found between statin use and cognitive decline in those with genetic risk factors for dementia.
Middle-aged people with the Alzheimer's related APOE4 gene have a harder time accessing recently acquired knowledge, even when they show no symptoms of memory decline.
Adding extra choline through eggs or meat to your daily diet could help stave off the effects of dementia. Higher phosphatidylcholine intake through diet was associated with lower rates of dementia and improved cognitive function in aging men.
Children with the APOE E4 gene perform lower on verbal and general IQ tests than their peers without the genetic risk factor. APOE E4 is a genetic risk factor for Alzheimer's disease. The study suggests the effects of the gene manifests before adulthood and could be the earliest biomarker for later vulnerability to Alzheimer's disease.
People with a family history of Alzheimer's disease perform worse on learning tasks than those without a genetic link to the disease. The learning impairments appear to be exacerbated by the APOE E4 gene and diabetes.
